NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









4D Biomaterials

4D Biomaterials

Private
NottinghamHealthcare & Life Scienceshttps://4dmedicine.co.uk/

Last Round

Series A

Jul 25, 2024

Total Funding Raised

$6.6M

Company Overview

4D Biomaterials is a medical device company that develops and manufactures 3D-printable, biodegradable polycarbonate resins for surgical implants.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

bioresorbable polymers3D printingmedical device manufacturingsurgical implantsregenerative medicinebiomaterialsbio-resorbablephotocurable resinshape-memory implantstissue engineeringmedical device designorthopedic implantsbio-printingresorbable implantscustom medical devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4D Biomaterials Comps

Public and private peers based on sector, stage, and business model.

4D Biomaterials comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

4D Biomaterials Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 25, 2024
SeedJul 28, 2021

4D Biomaterials Investors

Notable investors and investment history

4D Biomaterials investors
InvestorRounds
Oshen Holdings SASeries A
Mercia Asset ManagementSeed
SFC CapitalSeed, Series A
DSW VenturesSeries A, Seed
Boundary Capital PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2021

    $2.2M raised, led by DSW Ventures.

4D Biomaterials Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

4D Biomaterials Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 4D Biomaterials's valuation, stock price, and market status.

Firmographic Details

HeadquartersNottingham
Employee Range9
Year Founded2020
Last FundingJul 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.